Stable Isotope Labelled Vonlerolizumab Biosimilar – Anti-TNFRSF4/CD134 mAb – Research Grade

Reference: PX-TA1424-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Vonlerolizumab Biosimilar - Anti-TNFRSF4/CD134 mAb - Research Grade
SourceCAS 1638935-72-4
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsMOXR-0916,MOXR0916,RG-7888,RO7021608
ReferencePX-TA1424-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Vonlerolizumab Biosimilar - Anti-TNFRSF4/CD134 mAb - Research Grade

General information on Anti-TNFRSF4/CD134[Homo sapiens] (Vonlerolizumab) Monoclonal Antibody

Vonlerolizumab is investigated for thr treatment of Locally Advanced or Metastatic Urothelial Carcinoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Vonlerolizumab Biosimilar – Anti-TNFRSF4/CD134 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products